Francisco Leon, MD PhD, is a clinical immunologist who received his MD from Autónoma University in Madrid, Spain. In the Biotech and Pharmaceutical Industry, Francisco Leon has focused on early-stage development and translational research in immunologic diseases (rheumatoid arthritis, transplantation, IBD, psoriasis, celiac disease, asthma, etc) in Bristol-Myers Squibb, MedImmune, Alba Therapeutics and Centocor/Janssen. Francisco is also Adjunct Research Associate Professor of Medicine at Jefferson Medical College (Philadelphia). He has authored or co-authored over 60 peer-reviewed articles and book chapters as well as several patents.
Network with leading experts from the scientific and clinical arenas as well as investigators in industry to discuss novel findings and developments in immunological assays and procedures. Learn about recent advances in immunotherapy, as they relate to various modalities, specific cancers, cell subsets, and animal models. Discuss Potential clinical feasibility and commercial potential of the newest data obtained from leading biomedical research laboratories.
The 6th Immunotherapeutics & Immunomonitoring Conference is part of the Novel Immunotherapeutics Summit 2014, which includes three additional parallel conferences:12th Cytokines & Inflammation2nd Immunogenicity & ImmunotoxicityInaugural Innate Immunity
For more information, please visit http://www.gtcbio.com
GTC organizes conferences specifically for the biomedical and biopharmaceutical industries. Our goal is to facilitate the exchange of biopharmaceutical and biomedical intelligence between industry leaders, academic institutions, government organizations and the financial community.
GTC (Global Technology Community), LLC, is a privately held company founded in 2002.
| < Prev | Next > |
|---|






